These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3026000)

  • 1. Stability of sulbactam/ampicillin in diluents for parenteral administration.
    Mushinsky RF; Reynolds ML; Nicholson CA; Crider LL; Forcier GA
    Rev Infect Dis; 1986; 8 Suppl 5():S523-7. PubMed ID: 3026000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of sulbactam and ampicillin in serum and the myometrium.
    Schwiersch U; Lang N; Wildfeuer DA
    Drugs; 1986; 31 Suppl 2():26-8. PubMed ID: 3013570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The parenteral kinetics of ampicillin/sulbactam in man.
    Foulds G; Knirsch AK; Stankewich JP; Weidler DR
    Int J Clin Pharmacol Res; 1985; 5(2):79-86. PubMed ID: 2991150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid.
    Emmerson AM; Cox DA; Lees LJ
    Eur J Clin Microbiol; 1983 Aug; 2(4):340-4. PubMed ID: 6313357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary pharmacokinetics of sulbactam plus ampicillin in humans.
    Morris DL; Ubhi CS; Robertson CS; Brammer KW
    Rev Infect Dis; 1986; 8 Suppl 5():S589-92. PubMed ID: 3026008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of sulbactam and ampicillin administered concomitantly by intraarterial or intravenous infusion in the newborn.
    Sutton AM; Turner TL; Cockburn F; McAllister TA
    Rev Infect Dis; 1986; 8 Suppl 5():S518-22. PubMed ID: 3025999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Examination of pharmacokinetics and intestinal flora following 15 days of sultamicillin or ampicillin administration].
    Okada K; Kawamura N; Ikeda M; Ueno K; Yokota T; Nishiura T
    Kansenshogaku Zasshi; 1985 Jul; 59(7):749-65. PubMed ID: 2997343
    [No Abstract]   [Full Text] [Related]  

  • 8. The plasma kinetics of sulbactam-ampicillin administered to calves by the intramuscular and subcutaneous routes.
    Grimshaw WT; Colman PJ
    Br Vet J; 1987; 143(4):361-8. PubMed ID: 3040163
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of sultamicillin in mice, rats, and dogs.
    English AR; Girard D; Haskell SL
    Antimicrob Agents Chemother; 1984 May; 25(5):599-602. PubMed ID: 6329091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
    Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sulbactam/ampicillin in humans: a review.
    Foulds G
    Rev Infect Dis; 1986; 8 Suppl 5():S503-11. PubMed ID: 3025997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
    Brown RM; Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Apr; 21(4):565-7. PubMed ID: 6282211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
    Ball AP; Fox C; Ghosh D
    J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.
    Wright N; Wise R
    J Antimicrob Chemother; 1983 Jun; 11(6):583-7. PubMed ID: 6309731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulbactam kinetics and excretion into breast milk in postpartum women.
    Foulds G; Miller RD; Knirsch AK; Thrupp LD
    Clin Pharmacol Ther; 1985 Dec; 38(6):692-6. PubMed ID: 2998677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
    Houang ET; Colley N; Chapman M
    Antimicrob Agents Chemother; 1985 Jul; 28(1):165-6. PubMed ID: 2994556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 20. Compatibility and stability of diazepam injection following dilution with intravenous fluids.
    Morris ME
    Am J Hosp Pharm; 1978 Jun; 35(6):669-72. PubMed ID: 665679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.